PBPH Portfolio Building Block World Pharma and Biotech Index ETF
The Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) is designed to give investors specific exposure to the worldwide pharmaceutical and biotechnology sectors. These are recognized as some of the most rapidly evolving and research-intensive fields within healthcare. The ETF's objective is to emulate the returns of the BITA Global Pharma and Biotech Select Index, which tracks businesses operating in developed markets that generate a significant portion of their earnings from the invention, progression, and sale of treatments for human health.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| PBPH | +9.6% | +13.3% | +24.6% | — | — | — |
| Equity average (4725 funds) | -2.2% | -4.7% | +3008.3% | +1886.0% | +15.1% | +2.6% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$3K net.
Holdings · as of Nov 13, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | LLY.TO ELI LILLY & CO | 17.08% |
| 2 | JNJ.TO JOHNSON & JOHNSON | 9.53% |
| 3 | ABBV ABBVIE INC | 7.35% |
| 4 | MRK MERCK & CO. INC. | 5.13% |
| 5 | PBPH ROCHE HOLDING AG | 4.82% |
| 6 | AZN.L ASTRAZENECA PLC | 4.69% |
| 7 | AMGN AMGEN INC | 4.37% |
| 8 | NOVN.SW NOVARTIS AG-REG | 4.09% |
| 9 | GILD.TO GILEAD SCIENCES INC | 4.05% |
| 10 | PFE.BA PFIZER INC | 3.24% |
| 11 | VRTX VERTEX PHARMACEUTICALS INC | 2.66% |
| 12 | BMY BRISTOL-MYERS SQUIBB CO | 2.48% |
| 13 | SAN.PA SANOFI | 2.00% |
| 14 | REGN REGENERON PHARMACEUTICALS | 1.83% |
| 15 | MRNA MODERNA INC | 1.68% |
| 16 | CSL.AX CSL LTD | 1.28% |
| 17 | 4502.T TAKEDA PHARMACEUTICAL CO LTD | 1.26% |
| 18 | BAYN.DE BAYER AG-REG | 1.20% |
| 19 | ARGX ARGENX SE | 1.18% |
| 20 | TEVA.TA TEVA PHARMACEUTICAL IND LTD | 0.95% |
| 21 | NTRA NATERA INC | 0.83% |
| 22 | SDZNY SANDOZ GROUP AG | 0.81% |
| 23 | UCB.BR UCB SA | 0.74% |
| 24 | BIIB BIOGEN INC | 0.72% |
| 25 | ZTS ZOETIS INC | 0.66% |
| 26 | RVMD REVOLUTION MEDICINES INC | 0.62% |
| 27 | GMAB.CO Genmab A/S | 0.62% |
| 28 | ILMN ILLUMINA INC | 0.62% |
| 29 | 4578.T OTSUKA HOLDINGS CO LTD | 0.60% |
| 30 | 4503.T ASTELLAS PHARMA INC | 0.55% |
| 31 | 4568.T DAIICHI SANKYO CO LTD | 0.54% |
| 32 | 4519.T CHUGAI PHARMACEUTICAL CO LTD | 0.54% |
| 33 | RPRX ROYALTY PHARMA PLC- CL A | 0.53% |
| 34 | INSM INSMED INC | 0.51% |
| 35 | UTHR UNITED THERAPEUTICS CORP | 0.50% |
| 36 | HLN.L HALEON PLC | 0.48% |
| 37 | INCY INCYTE CORP | 0.47% |
| 38 | VTRS VIATRIS INC | 0.46% |
| 39 | MRK.DE MERCK KGAA | 0.44% |
| 40 | ALNY ALNYLAM PHARMACEUTICALS INC | 0.41% |
| 41 | EXEL EXELIXIS INC | 0.35% |
| 42 | NBIX NEUROCRINE BIOSCIENCES INC | 0.35% |
| 43 | JAZZ JAZZ PHARMACEUTICALS PLC | 0.31% |
| 44 | ELAN ELANCO ANIMAL HEALTH INC | 0.27% |
| 45 | 4507.T SHIONOGI & CO LTD | 0.26% |
| 46 | GALD.SW GALDERMA GROUP AG | 0.25% |
| 47 | BBIO BRIDGEBIO PHARMA INC | 0.23% |
| 48 | BMRN BIOMARIN PHARMACEUTICAL INC | 0.23% |
Sector breakdown
Country breakdown
Distributions
| Date | Per unit |
|---|---|
| Dec 24, 2025 | $0.0230 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in PBPH in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error